BMY•benzinga•April 24, 2025 at 11:01 AM

Bristol-Myers Squibb Raises FY2025 Adj EPS Guidance from $6.55-$6.85 to $6.70-$7.00 vs $6.74 Est; Raises FY2025 Sales Guidance from $45.50B to $45.80B-$46.80B vs $45.76B Est

No summary available.

Read the full article from the original source for complete details and context.

Article published on April 24, 2025 by benzinga